GlassScriptPhysician profile
Mythili Gurram
NPI 1285722322
$1,349.83
in general payments reported to CMS, 2019-2025
20 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $61.86 · 2021: $205 · 2022: $289 · 2023: $218 · 2024: $146 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $234.35 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $190.43 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $183.91 | 2021-2025 | Dupixent |
| Amgen INC. | $152.47 | 2020-2025 | Tavneos, Evenity |
| Travere Therapeutics, INC. | $124.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $83.05 | 2019-2023 | Breztri |
| Novartis Pharmaceuticals Corporation | $70.79 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $48.18 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $35.60 | 2021 | |
| Genzyme Corporation | $34.57 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.03 | 2021 | |
| Galderma Laboratories, L.P. | $27.22 | 2025 | Nemluvio |
| Kaleo, INC. | $25.47 | 2019 | |
| Covis Pharma Gmbh | $18.90 | 2022 | |
| Abbvie INC. | $18.20 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.05 | 2021 | |
| Avanir Pharmaceuticals, INC. | $15.28 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.93 | 2021 | |
| Lilly USA, LLC | $13.20 | 2023 | Jardiance |
| Lundbeck LLC | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mythili Gurram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.